NCT05486832View on ClinicalTrials.gov

Safety and Performance of the Cardiovalve TR Replacement System

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 9, 2022

Primary Completion Date

August 15, 2026

Study Completion Date

December 15, 2026

Conditions
Tricuspid Regurgitation
Interventions
DEVICE

Cardiovalve TR valve replacement System

The Cardiovalve system includes a valve and delivery system, designed for replacement of the tricuspid valve through a transcatheter.

Trial Locations (7)

10117

RECRUITING

Charité university, Berlin

20251

RECRUITING

Universitäres Herz, Hamburg

RECRUITING

University Heart Center Lübeck, Lübeck

32545

RECRUITING

Universität Bochum, Bad Oeynhausen

50937

RECRUITING

Herzzentrum Uniklinik, Cologne

53127

RECRUITING

Uniklinik Bonn, Bonn

93053

RECRUITING

Universitätsklinikum - Regensburg, Regensburg

Sponsors

Lead Sponsor

Cardiovalve Ltd.
All Listed Sponsors
lead

Cardiovalve Ltd.

INDUSTRY

NCT05486832 - Safety and Performance of the Cardiovalve TR Replacement System | Biotech Hunter | Biotech Hunter